NO321154B1 - Fremgangsmate ved fremstilling av mometason furoat - Google Patents

Fremgangsmate ved fremstilling av mometason furoat Download PDF

Info

Publication number
NO321154B1
NO321154B1 NO19995225A NO995225A NO321154B1 NO 321154 B1 NO321154 B1 NO 321154B1 NO 19995225 A NO19995225 A NO 19995225A NO 995225 A NO995225 A NO 995225A NO 321154 B1 NO321154 B1 NO 321154B1
Authority
NO
Norway
Prior art keywords
mometasone
reaction
furoate
solvent
furoyl chloride
Prior art date
Application number
NO19995225A
Other languages
English (en)
Norwegian (no)
Other versions
NO995225L (no
NO995225D0 (no
Inventor
William Heggie
Joao Bandarra
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of NO995225D0 publication Critical patent/NO995225D0/no
Publication of NO995225L publication Critical patent/NO995225L/no
Publication of NO321154B1 publication Critical patent/NO321154B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19995225A 1999-08-02 1999-10-26 Fremgangsmate ved fremstilling av mometason furoat NO321154B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (3)

Publication Number Publication Date
NO995225D0 NO995225D0 (no) 1999-10-26
NO995225L NO995225L (no) 2001-02-05
NO321154B1 true NO321154B1 (no) 2006-03-27

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995225A NO321154B1 (no) 1999-08-02 1999-10-26 Fremgangsmate ved fremstilling av mometason furoat

Country Status (22)

Country Link
US (1) US6177560B1 (zh)
EP (1) EP1074558B1 (zh)
JP (1) JP3746174B2 (zh)
KR (1) KR100640066B1 (zh)
CN (1) CN1149222C (zh)
AT (1) ATE229970T1 (zh)
AU (1) AU765592B2 (zh)
CA (1) CA2295455C (zh)
DE (1) DE69904585T2 (zh)
DK (1) DK1074558T3 (zh)
ES (1) ES2189354T3 (zh)
HR (1) HRP990341B1 (zh)
HU (1) HU227494B1 (zh)
IL (1) IL133752A (zh)
NO (1) NO321154B1 (zh)
NZ (1) NZ500555A (zh)
PL (1) PL191103B1 (zh)
PT (1) PT102343B (zh)
RU (1) RU2208616C2 (zh)
SI (1) SI1074558T1 (zh)
UA (1) UA60333C2 (zh)
ZA (1) ZA996758B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
LT2435023T (lt) * 2009-05-29 2016-09-26 Pearl Therapeutics, Inc. Kompozicijos, skirtos ilgai veikiančių muskarininių antagonistų ir ilgai veikiančių beta-2-adrenerginio receptoriaus agonistų pristatymui į plaučius, ir susiję būdai bei sistemos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CA2912927A1 (en) 2013-05-22 2014-11-27 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of three or more active agents
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
IL309888A (en) 2021-07-09 2024-03-01 Astrazeneca Pharmaceuticals Lp Aerosol drug delivery compounds, methods and systems
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
NZ333410A (en) * 1996-06-28 2000-06-23 Schering Corp Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
ATE229970T1 (de) 2003-01-15
ES2189354T3 (es) 2003-07-01
KR20010020094A (ko) 2001-03-15
ZA996758B (en) 2000-08-30
HU227494B1 (en) 2011-07-28
NO995225L (no) 2001-02-05
CN1149222C (zh) 2004-05-12
US6177560B1 (en) 2001-01-23
SI1074558T1 (en) 2003-04-30
JP2001048897A (ja) 2001-02-20
HUP9903747A2 (hu) 2001-05-28
AU765592B2 (en) 2003-09-25
HRP990341A2 (en) 2001-04-30
JP3746174B2 (ja) 2006-02-15
KR100640066B1 (ko) 2006-10-31
EP1074558B1 (en) 2002-12-18
HRP990341B1 (en) 2003-10-31
PL336452A1 (en) 2001-02-12
NO995225D0 (no) 1999-10-26
CN1282744A (zh) 2001-02-07
AU5602499A (en) 2001-02-08
PT102343B (pt) 2003-11-28
EP1074558A1 (en) 2001-02-07
CA2295455A1 (en) 2001-02-02
IL133752A0 (en) 2001-04-30
IL133752A (en) 2004-02-19
PL191103B1 (pl) 2006-03-31
DK1074558T3 (da) 2003-04-07
CA2295455C (en) 2008-03-25
HU9903747D0 (en) 1999-12-28
NZ500555A (en) 2000-11-24
UA60333C2 (uk) 2003-10-15
DE69904585D1 (de) 2003-01-30
PT102343A (pt) 2001-02-28
DE69904585T2 (de) 2003-05-15
RU2208616C2 (ru) 2003-07-20
HUP9903747A3 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
NO321154B1 (no) Fremgangsmate ved fremstilling av mometason furoat
AU725606B2 (en) Process for the preparation of 17-esters of 9alpha,21- dihalo-pregnane-11beta,17alpha-diol-20-ones
CZ20023472A3 (cs) Způsob výroby meziproduktu
US4482706A (en) Steroid saponins
EP2262823B1 (en) Process for the preparation of pregnane derivatives
CN114957368A (zh) 中间体化合物及其制备方法和应用
CN107629107B (zh) 一种醋酸乌利司他的合成方法
US2705232A (en) Ternorcholanylthiazoles
MXPA00000670A (es) Proceso para la preparacion de furoato de mometasona
EP0240338B1 (en) Butenoic acid derivatives
CN115785188B (zh) 一种布地奈德的制备方法
JPS60181096A (ja) 胆汁酸の精製方法
US3697510A (en) Novel preparation of pregnanes
JP2547322B2 (ja) ブラシノステロイド化合物及びその製法
AU2022326764A1 (en) Synthesis of delta 9,11 steroids
JP2631472B2 (ja) ブラシノステロイド誘導体及びその製造法
SU499810A3 (ru) Способ выделени -кето-2-дибензофуранмасл ной кислоты
JPH07267986A (ja) 5α−コレスタ−8(14)−エン−3β−オール−15−オンおよび他の15−酸素化ステロールの合成のための改良方法
JPH051053A (ja) 6−(3−ジメチルアミノプロピオニル)フオルスコリンの新規製造法
PL201837B1 (pl) Związek 9-deoksy-9(Z)-hydroksyiminoerytromycyny A
JPH0146517B2 (zh)
JPH0739435B2 (ja) 24―オン―ブラシノステロイド誘導体
FR2689128A1 (fr) Procédé de préparation de l'acide alpha-méthyl 5-benzoyl 2-thiophène acétique optiquement actif et intermédiaires.
DD295856A5 (de) Verfahren zur herstellung von 21-acyloxy-pregna-1,4,16-trien-3,20-dion

Legal Events

Date Code Title Description
MK1K Patent expired